You may find more results for this query on our sister sites: 360Dx and Precision Oncology News.
Researchers use the CRISPR/Cas9 gene editing approach to limit herpesviruses replication.
In addition to the hepatitis C panel, the company offers a number of next-generation sequencing-based tests including one for colorectal cancer.
A German clinical lab found that the test, run on Hologic's Panther system, was slightly more sensitive than a Roche assay on the High Pure System.
Enzo's fiscal first quarter revenues grew 2 percent year over year to $25.2 million, driven by an 8 percent spike in clinical laboratory services.
Following a beta evaluation of the system, a virology lab in Sheffield, UK, ran a workflow assessment and found improvements with the system.
The tests are the first assays approved by the FDA to run on the firm's Cobas 6800 and Cobas 8800 systems.
The DxN Veris was recently launched as a CE-marked product with a menu of viral load tests, and will launch in a few years in the US with STD and HAI assays.
The new assay uses high-resolution melt curve analysis to detect variations in genes that lead some people to spontaneously clear hepatitis C viral infections.
The assays add to the test menu of Beckman Coulter's DxN Veris molecular diagnostics system.
Three new assays were presented in posters at April's Clinical Virology Symposium.
Politico reports that the NYPD DNA database has grown since it announced it would be removing profiles from it.
Forbes reports that a structural biology lab at Oxford University studying the coronavirus was hacked.
Science reports that a Dutch research funding agency is combating a ransomware attack.
In Science this week: set of 64 haplotype assemblies from 32 individuals, and more.